AdaptHealth layoffs, on the record
Every job cut, severance charge and restructuring AdaptHealth reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from approximately 10,700 to approximately 10,900.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | approximately 10,700 | December 31, 2023 |
| 10-K for 2024 | approximately 10,500 | December 31, 2024 |
| 10-K for 2025 | approximately 10,900 | December 31, 2025 |
Job cuts, severance and restructuring
Our summaryThe company recorded severance charges in 2023, including amounts tied to the separation of its former CEO.
Word for word“The 2023 period consists of $13.9 million of expenses associated with litigation, $7.1 million of severance charges (of which $2.9 million relates to the separation of the Company's former CEO), $5.6 million of consulting expenses associated with systems implementation activities, $5.2 million of consulting expenses associated with cost savings initiatives, $4.8 million of lease termination costs associated with a cost management program, $0.9 million of net impairments of operating lease right-of-use assets as a result of vacating the leased facilities, and $1.6 million of other non-recurring expenses, offset by income of $2.5 million related to changes in AdaptHealth's estimated TRA liability.” 10-K for 2023
Our summaryA regional manager left the company under a separation agreement providing severance and separation benefits, and then agreed to a short-term consulting arrangement.
Word for word“The regional manager left the Company effective March 31, 2023 via a separation agreement which provides severance and separation benefits, including a pro rata bonus.” 10-K for 2023
Our summaryThe company recorded severance charges of $3.8 million in 2024 in general and administrative expenses, of which $3.0 million related to the separation of the former President.
Word for word“General and administrative expenses in 2024 included $11.3 million of equity-based compensation expense, and other non-recurring expenses of $28.7 million, consisting of $13.9 million of consulting expenses associated with systems implementation activities, $4.5 million of consulting expenses associated with asset dispositions, $4.2 million of expenses associated with litigation, $3.8 million of severance charges (of which $3.0 million relates to the separation of the Company's former President), and $2.3 million of other expenses, primarily related to professional and consulting expenses.” 10-K for 2024
Our summaryThe former President resigned from all positions on August 31, 2024, and 311,018 time-vesting and 391,408 performance-vesting restricted stock units were forfeited, with $3.3 million of equity compensation expense reversed.
Word for word“As previously disclosed, by mutual agreement with the Company, the Company's former President resigned from all positions held with the Company on August 31, 2024 and served as a non-executive member of the board of directors until December 31, 2024.” 10-K for 2024
Our summaryA cost savings program implemented in 2023 produced restructuring expenses, which lowered 2024 G&A compared with 2023.
Word for word“This increase is primarily due to higher salaries, labor and benefits, professional and consulting fees, software costs, and increased legal reserves, partially offset by lower equity-based compensation expense and restructuring expenses related to a cost savings program that was implemented in 2023.” 10-K for 2024
Our summaryLabor cost in the Wellness at Home segment decreased due to reductions in headcount in the segment's comparison period.
Word for word“The decrease in labor cost was primarily due to reductions in headcount.” 10-K for 2024
Our summaryThe company recorded severance charges in 2025, along with consulting costs for a reorganization project, as part of non-recurring expenses.
Word for word“(g) The 2025 period consists of $10.7 million of consulting expenses associated with asset dispositions (of which $5.1 million relates to contingent success fees from the sales of businesses), $2.6 million of transaction costs associated with acquisitions, $2.6 million of consulting expenses associated with a reorganization project, $2.4 million of consulting expenses associated with systems implementation activities, $1.6 million of expenses associated with securities litigation, $1.2 million write-off of assets, $1.2 million of severance charges, and $3.6 million of other non-recurring expenses.” 10-K for 2025
| Fiscal year ended | Severance costs |
|---|---|
| 2019-12-31 | $858,000 |
| 2020-12-31 | $4.5 million |
| 2021-12-31 | $2 million |
| 2023-12-31 | $7.1 million |
| 2024-12-31 | $3.9 million |
| 2025-12-31 | $1.2 million |
AdaptHealth has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from AdaptHealth’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-24. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.